Similarly, in our cohort of liver specimens from patients with histologically confirmed end-stage MASH, among all the regulators of glyoxylate metabolism or oxalate formation, only AGXT was significantly suppressed as compared to healthy donors. Here, AGXT is linked to metabolic dysfunction-associated steatohepatitis.